ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VOR Vor Biopharma Inc

1.7062
0.0062 (0.36%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vor Biopharma Inc VOR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0062 0.36% 1.7062 08:00:01
Open Price Low Price High Price Close Price Previous Close
1.71 1.65 1.719 1.69 1.70
more quote information »

Recent News

Date Time Source Heading
01/4/202423:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
21/3/202407:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
05/3/202400:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
15/2/202408:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202400:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
03/2/202408:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/2/202411:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202411:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202408:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
06/1/202409:03EDGAR2Form 8-K - Current report
22/12/202308:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/12/202308:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
28/11/202300:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
10/11/202308:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
09/11/202308:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202308:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
08/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202307:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03/11/202323:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
03/11/202300:10EDGAR2Form 8-K - Current report
03/11/202300:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
04/10/202307:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25/9/202322:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
07/9/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202306:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202322:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
11/8/202306:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
11/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202322:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..
09/6/202321:30GLOBESuccessful Primary Engraftment of Trem-cel in First Five AML..
05/6/202322:00GLOBEVor Bio to Participate in the Goldman Sachs Healthcare..
12/5/202306:05GLOBEVor Bio Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock